To hear about similar clinical trials, please enter your email below
Trial Title:
Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon
NCT ID:
NCT06640075
Condition:
Cervical Cancer Screening
Conditions: Official terms:
Uterine Cervical Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
cluster-randomized controlled trial
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Community co-produced action
Description:
Participatory workshops will be conducted with community members by a multidisciplinary
team with the aim to co-develop a strategy for cervical cancer screening adapted to the
local setting (including primary HPV screening, triage of HPV-positive patients and
treatment of patients triaged positive). This intervention is referred to as 'community
co-produced action'. Possible strategies co-developed may include collaboration with
community health workers or local associations, awareness campaigns, development of
health education materials, integration of primary HPV screening at local integrated
health centers, organization of group transportation to the district screening center,
etc.
Using purposive sampling methods, approximately 15 participants will be invited to take
part in the workshops in each health area of the intervention, including approximately 3
health care providers, 3 community health workers or members of women's associations, 3
men and 6 eligible women for screening.
Arm group label:
Community co-produced action
Intervention type:
Other
Intervention name:
Standard screening strategy
Description:
Recruitment of study participants will be coordinated centrally at district level (from
the Bafoussam Regional Hospital) following procedures previously established in a
cervical cancer screening program in the health district of Dschang. This standard
procedure includes the training of 2 community health workers (CHW) by health area to
raise awareness around cervical cancer. After an initial theoretical and practical
training in cervical cancer prevention, CHWs recruit women by going door-to-door or
through community meetings in their respective health areas. Through a system of nominal
invitation vouchers distributed to eligible women, CHWs receive a financial incentive for
each woman that shows up for cervical cancer screening. Twice a year, CHWs of all health
areas are invited to a feedback session to discuss difficulties encountered on the field
and propose solutions to face any identified challenges.
Arm group label:
Standard screening strategy
Summary:
Background - The burden of cervical cancer is unequally distributed globally, with over
90% of deaths occurring in low- and middle-income countries (LMICs), mainly due to
insufficient uptake of preventive measures such as screening. In 2020, the World Health
Organization launched a global initiative for the worldwide elimination of cervical
cancer as a public health issue, setting a target of 70% of women screened with a
high-performance test. In Cameroon, this target is far from being reached, and rural
communities are disproportionately affected by low uptake of screening services.
Recently, a new cervical cancer screening program has launched in the Bafoussam Regional
Hospital, in the capital of the Mifi Health District, as part of a larger research
project. To develop a context-specific strategy improving access to screening for women
living in rural areas of the district, the active participation of community members for
the co-development and implementation of local strategies for cervical cancer screening
may be key to improving population screening coverage.
Objective - The aim of this study is to evaluate the use of community co-produced action
(CCA) for the development and implementation of HPV-based cervical cancer screening
strategies compared to a traditional hospital-based approach in rural areas of the Mifi
Health District in Cameroon.
Methods - Using a cluster-randomized study design, participatory workshops with community
members will be led in 7 rural health areas assigned to the intervention arm, with the
aim of codeveloping local strategies for HPV-based cervical cancer screening adapted to
the setting. The co-produced strategies may include raising awareness among eligible
women (aged 30-49 years, or 25-49 years if HIV-positive), as well as facilitating access
to screening tests, results and follow-up. Women living in one of the 7 health areas
assigned to the control arm will be invited by community health workers to undergo
screening at the Bafoussam Regional Hospital. In both study arms, screened women will be
included in the GENOVA study, a cervical cancer screening trial offering free-of- charge
HPV testing followed by triage by visual inspection or genotyping for HPV-positive women,
and free treatment according to triage results. CCA will be evaluated by assessing its
effectiveness for screening uptake. Screening coverage among eligible women will be
estimated during one year after implementation of screening strategies in both study
arms, based on population statistics provided by the Mifi health district for each health
area.
Expected results - Developing context-sensitive solutions to cervical cancer screening
through a community-based participatory approach in rural areas of the Mifi health
district is expected to improve screening participation rate.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Women aged 30-49 years old (25-49 years old if HIV-positive)
- Residency in one of the 14 rural health areas of Mifi health district
- Ability to give signed informed consent
Exclusion Criteria:
- known cervical cancer
- symptoms compatible with cervical cancer
- previous hysterectomy
- terminal disease other than cervical cancer
- cervical cancer screening test in the last 5 years (3 years if HIV-positive)
- pregnancy at the time of screening
- lack of discernment capacity
Gender:
Female
Minimum age:
25 Years
Maximum age:
49 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Bafoussam Regional Hospital
Address:
City:
Bafoussam
Zip:
00237
Country:
Cameroon
Status:
Recruiting
Contact:
Last name:
Loïc Djommo, MSc
Phone:
+237696254802
Email:
metchehe00@gmail.com
Investigator:
Last name:
Georges Enow Orock, MD
Email:
Principal Investigator
Start date:
April 13, 2024
Completion date:
December 2026
Lead sponsor:
Agency:
Prof. Patrick Petignat
Agency class:
Other
Collaborator:
Agency:
University Hospital, Geneva
Agency class:
Other
Collaborator:
Agency:
Bafoussam Regional Hospital, Cameroon
Agency class:
Other
Collaborator:
Agency:
London School of Hygiene and Tropical Medicine
Agency class:
Other
Source:
University Hospital, Geneva
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06640075